Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New DNA tests to help prevent blindness in border collies
"We hope our research will help to reduce the number of dogs that go blind from this disease.”
Genetic mutation found to be responsible for severe gonio 

Scientists have discovered a mutation in the OLFML3 gene which causes sudden blindness in border collies.

The findings have resulted in several companies developing genetic tests for the condition, called goniodysgenesis - or gonio - to avoid affected dogs being used to produce puppies.

In severe gonio, the affected dog’s eyes do not develop properly, which can cause glaucoma, leading to sudden loss of sight. Sudden blindness in border collies was first seen in Australia in the late 90s, then in the UK in relatives of the original dogs. Breeders suspected there may be a genetic cause.

Researchers from the Roslin Institute collected DNA from dog saliva samples and compared those with healthy eyes, to those with symptoms of severe gonio. They found a genetic mutation in OLFML3, which is involved in the early stages of eyeball development.

All dogs who suffered blindness had two copies of the mutation gene. The research paper has been published in the journal G3: Genes, Genomes, Genetics.

Dr Carys Pugh, from the University of Edinburgh, said: “We are delighted that our findings have directly led to a genetic test for this condition. We hope our research will help to reduce the number of dogs that go blind from this disease.”

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.